Pitfalls of technology licensing, urgent need for training among issues covered at panel discussion on Taiwan’s biologics business environment

To take advantage of its strong science base and a growing number of small innovative companies, Taiwan’s burgeoning biopharmaceutical industry will need to start planning now to develop personnel skilled enough in GMP manufacturing and clinical trials to meet the demands and rigors of such a highly technical field.

Read more